Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Limaprost versus celecoxib for residual paresthesia after lumbar fusion surgery
ChiCTR2400092866Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Southern Medical University
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in degenerative lumbar spinal stenosis (LSS) comparing Limaprost tablet group with Celecoxib group (2 arms). Primary endpoint: Improvement rate of VAS score after 3 months of treatment. Started Nov 2024; status: recruiting.
02
Drugs
limaprostcelecoxib
03
Conditions
degenerative lumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on ChiCTR2400092866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092866.